Full-Time

Quality Inspector

Prestige Brands

Prestige Brands

201-500 employees

Over-the-counter health and wellness products

Compensation Overview

$17.50 - $22/hr

Lynchburg, VA, USA

In Person

Category
Manufacturing Quality & Test (1)
Required Skills
Quality Assurance (QA)

Get referred to Prestige Brands

See people who can refer or advise you

Requirements
  • A high school diploma is required.
  • A minimum of two years of experience in an inspection and/or testing-related field is required, preferably in a good manufacturing practice or regulated industry.
  • The ability to perform significant walking and standing is required.
  • The ability to climb ladders for sampling is required.
  • The ability to lift up to 50 pounds is required.
  • Applicants must not be colorblind.
  • Employees must adhere to company procedures and good manufacturing practice regulations.
Responsibilities
  • Perform routine and moderately complex sampling, inspections, and appropriate physical, functional, and dimensional testing of incoming raw materials, packaging components, and finished goods.
  • Perform quality inspection activities in accordance with company procedures and within required timelines.
  • Inspect and test packaging components using measuring devices such as scales, micrometers, and height gauges to determine conformance with specifications.
  • Perform quality checks of finished goods during production and document the results.
  • Use proper gowning and sampling techniques to sample containers, prepare samples for chemical and required microbiological analysis, and deliver them to the quality control laboratory.
  • Evaluate inspection results against established specifications.
  • Review physical analysis reports for accuracy and compliance and disposition materials based on inspection results.
  • Support other Quality Assurance activities, including issuing controlled documents and reviewing documents.
  • Maintain the sampling booth, laboratory, and surrounding area through routine cleaning.
  • Perform daily verification checks of scales used in the production area.
  • Support the retain storage program by placing samples in the program, conducting annual inspections according to established procedures, and removing samples.
  • Resolve quality-related issues in a timely manner.
  • Maintain equipment and work areas in a safe, clean, and organized condition.
  • Assist in opening events for activities associated with the manufacturing, processing, packing, inspection, testing, or holding of drug products, drug product components, or raw materials that are out of the ordinary and may affect product identity, strength, quality, safety, or process efficiency.
  • Perform other related duties as required.
Desired Qualifications
  • Experience in a good manufacturing practice or regulated industry is preferred.

Prestige Consumer Healthcare focuses on consumer health and wellness products sold worldwide. It develops and markets over-the-counter medicines and related wellness products that are designed for everyday health needs and easy use, with a broad, globally distributed portfolio. Unlike some peers that operate in niche markets or regional scopes, Prestige Consumer Healthcare emphasizes a global reach with widely available brands that address common health concerns. Its goal is to help people manage everyday health issues through accessible, affordable products and a consistent consumer-brand experience across markets.

Company Size

201-500

Company Stage

IPO

Headquarters

Town of Greenburgh, New York

Founded

1996

Get referred to Prestige Brands

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 6, 2026 Q1 revenue rose 6.5% to $265.7 million, beating expectations.
  • Breathe Right and LaCorium added about $190 million revenue guidance for fiscal 2027.
  • E-commerce and core GI and skincare brands delivered double-digit consumption growth in 2026.

What critics are saying

  • Clear Eyes supply failures at Pillar5 still cut sales and can drag fiscal 2027.
  • June 2026 Breathe Right financing lifted net debt near $2 billion and leverage above 4x.
  • Ongoing 2026 securities investigations around May 13 guidance and Clear Eyes create headline overhang.

What makes Prestige Brands unique

  • Prestige owns category-synonymous brands like Breathe Right, Dramamine, Monistat, and Clear Eyes.
  • Management integrated Breathe Right within 60 days, proving repeatable acquisition execution.
  • The company generates outsized cash, turning modest growth into $83.7 million Q1 free cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Paid Vacation

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Life Insurance

Health Savings Account/Flexible Spending Account

Tuition Reimbursement

Performance Bonus

Company News

Yahoo Finance
Aug 6th, 2026
Prestige Consumer Healthcare beats Q1 expectations with $106.3M record cash flow

Prestige Consumer Healthcare exceeded expectations in Q1 fiscal 2027, with total sales rising 6.5% to approximately $266 million. The company delivered record quarterly adjusted free cash flow of $83.7 million. The firm completed two strategic acquisitions — Breathe Right and Lacorium Health — expected to add over 20% to annualised revenue. The Breathe Right portfolio, contributing approximately $200 million in annual revenue, was integrated within 60 days of closing. Management raised full-year fiscal 2027 adjusted diluted earnings per share guidance to $4.55–$4.65 and adjusted free cash flow guidance to $270 million or more. Strong consumption growth was seen in gastrointestinal and skincare categories, with robust double-digit growth in e-commerce. However, Clear Eyes sales disappointed due to ongoing supply constraints. The company anticipates modest organic revenue decline in Q2 due to retailer order timing that benefited Q1.

Yahoo Finance
Aug 6th, 2026
Prestige Consumer Healthcare Q1 revenue hits $265.7M, beating estimates by 6%

Prestige Consumer Healthcare reported revenue of $265.71 million for the quarter ended June 2026, a 6.5% year-over-year increase. The company posted earnings per share of $0.98, up from $0.95 in the same period last year. The revenue figure exceeded the Zacks Consensus Estimate of $250.25 million by 6.18%. EPS also surpassed expectations, beating the $0.89 consensus estimate by 10.11%. North American OTC Healthcare revenues reached $226.21 million, whilst International OTC Healthcare generated $39.5 million, both segments showing growth compared to analyst estimates. Shares of Prestige Consumer Healthcare have returned 9.7% over the past month, outperforming the S&P 500's 3.3% gain. The stock currently carries a Zacks Rank of 4, indicating potential near-term underperformance versus the broader market.

Associated Press
Aug 6th, 2026
Prestige Consumer Healthcare Q1 revenue up 6.5% to $266M, raises full-year outlook to $1.3B

Prestige Consumer Healthcare reported first quarter fiscal 2027 revenue of $265.7 million, up 6.5% year-over-year, with organic sales growth of 3.2%. Adjusted diluted earnings per share reached $0.98, compared to $0.95 in the prior year period. The company closed acquisitions of Breathe Right and LaCorium Health in June and July, respectively. Breathe Right contributed $5.9 million to quarterly revenue. First quarter adjusted free cash flow hit a record $83.7 million, up from $78.2 million the previous year. The company's net debt position stood at approximately $2 billion as of 30 June 2026. Prestige raised its full-year fiscal 2027 outlook to reflect the acquisitions, now expecting revenue of $1.29 billion to $1.315 billion and adjusted diluted EPS of $4.55 to $4.65.

Yahoo Finance
Jul 3rd, 2026
Prestige Consumer Healthcare closes $1B Breathe Right acquisition, plans category expansion

Prestige Consumer Healthcare has closed its largest acquisition, purchasing the Breathe Right brand and other over-the-counter labels from Foundation Consumer Healthcare for $1.045 billion. The deal, completed on 15 June, brings in approximately $200 million in annual revenue and $95 million in EBITDA. The acquisition includes Breathe Right nasal strips, Dimetapp children's cough medicine and Anbesol oral pain relief. Breathe Right is now Prestige's largest brand, with potential expansion beyond sleep wellness into athletic performance and allergy relief. CEO Ron Lombardi plans to replicate the company's successful Dramamine strategy, which transformed that brand from a motion sickness remedy into a broader nausea treatment. Prestige focuses on "category synonymous" brands, with roughly 64% of revenues coming from brands holding number one positions in their categories.

Yahoo Finance
Jun 2nd, 2026
Canaccord cuts Prestige Consumer Healthcare price target to $72 after Q4 eye care weakness

Canaccord Genuity reduced its price target on Prestige Consumer Healthcare Inc. from $86 to $72 whilst maintaining a Buy rating, following weaker fourth-quarter results. The downgrade was attributed to softness in the eye care segment and additional pressure related to the Iran conflict. Separately, Prestige Consumer Healthcare announced on 13 May a definitive agreement to acquire LaCorium Health for approximately $150 million in cash. LaCorium generated roughly $40 million in revenue over the trailing twelve months ending 28 February and is expected to contribute around $12 million in EBITDA post-integration. The transaction is expected to close during the second quarter of fiscal 2027, subject to standard closing conditions.